VSTM today
$8.23-$0.21 (-2.49%)close Nov 13, 2026Trend
DailyUptrend (starting)
4 hourBearish
1 hourStrong Bearish
15 minLeaning Bullish
5 minBullish
Daily trend turns down below $6.70
Key levels
Resistance$10.10
Resistance$8.60
Support$7.72
Support$6.70
Latest news & SEC filings
AnalystRBC Capital Markets changes its price target for Verastem
AnalystRBC Capital keeps Outperform rating on Verastem, cuts price target to $18
AnalystHC Wainwright keeps Buy rating on Verastem, lifts target to $20
All VSTM news →About Verastem
Verastem is a biopharmaceutical company focused on cancers driven by RAS/MAPK pathway mutations. It sells a co-pack of avutometinib and defactinib in the United States for a type of recurrent ovarian cancer in patients whose tumors carry a KRAS mutation. The company also runs clinical trials of avutometinib with defactinib in pancreatic cancer and of a pill that blocks a specific KRAS mutation in solid tumors including pancreatic, lung, and colorectal cancers.
Based on the company's 10-K filed Mar 4, 2026.
Nasdaq · Healthcare
Verastem, Inc. (VSTM)
What Is the Price Target for VSTM?
SEPT Low Target
$12.00
SEPT Mid Target
$18.00
SEPT High Target
$24.00
Analyst Consensus
$18.00
Is VSTM a Buy or Sell Right Now?
Thesis
- •Revenue growing 209.1% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for VSTM.
Start Free Trial →Is VSTM Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
P/B, Analyst Consensus
Fair Value
$13.80
17
Moat Score
NONE
5/9
Piotroski Score
-6.0
Altman Z-Score
What Is Smart Money Doing with VSTM?
Insider Signal
SELLING
0 buys / 6 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Paterson Dan | director officer | Sale | 1,299 | $12K | Nov 3, 2026 |
| Calkins Daniel | officer | Sale | 55 | $423.50 | Sep 21, 2026 |
| BAILEY MICHAEL P | director | Buy | 108,000 | - | May 21, 2026 |
| Tollefson Karin Anna | director | Buy | 36,000 | - | May 21, 2026 |
| Stuglik Brian M | director | Buy | 36,000 | - | May 21, 2026 |
| Rowinsky Eric K | director | Buy | 36,000 | - | May 21, 2026 |
| ROBERTSON MICHELLE | director | Buy | 36,000 | - | May 21, 2026 |
| Kapur Anil | director | Buy | 36,000 | - | May 21, 2026 |
| Bunn Paul A. | director | Buy | 36,000 | - | May 21, 2026 |
| JOHNSON JOHN | director | Buy | 36,000 | - | May 21, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →VSTM Growth Story
Revenue YoY
209.1%
3yr Revenue CAGR
146.9%
EPS Growth YoY
17.49%
FCF Growth YoY
N/A%
Revenue Trend
ACCELERATING
Dark Pool Trades for VSTM
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for VSTM, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 18:49:11 | $8.21 | 1,000 | $$8K | BUY |
| 18:22:19 | $8.25 | 3,100 | $$26K | MIDPOINT |
| 18:22:19 | $8.25 | 2,915 | $$24K | BUY |
| 18:02:10 | $8.19 | 1,000 | $$8K | BUY |
| 17:39:32 | $8.18 | 2,500 | $$20K | BUY |
5 dark pool trades shown · $$86K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for VSTM
PREVIEWSEPT Investing provides real-time options flow tracking for VSTM, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $12 | Jan 15 | 63 | $$120 | 3 | SWEEP |
| CALL | $12 | Jan 15 | 63 | $$120 | 3 | SWEEP |
| CALL | $12 | Jan 15 | 63 | $$40 | 1 | SWEEP |
| CALL | $12 | Jan 15 | 63 | $$40 | 1 | SWEEP |
| CALL | $12 | Jan 15 | 63 | $$120 | 3 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Verastem, Inc. (VSTM) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (4 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →VSTM — frequently asked questions
What is VSTM stock price today?
Verastem, Inc. (VSTM) is at $8.23, down 2.49% (-$0.21) at the Nov 13, 2026 close.
Why is VSTM stock moving today?
Latest VSTM news — Nov 6, 2026: RBC Capital Markets changes its price target for Verastem · Nov 6, 2026: RBC Capital keeps Outperform rating on Verastem, cuts price target to $18
Why did VSTM stock move on Oct 15, 2026?
Verastem (VSTM) shares surged 14.09% today, closing at $9.23 on heavy volume of over 11 million shares. The rally was driven by multiple analyst upgrades, with Jefferies maintaining a Buy rating and raising its price target to $13, while RBC Capital maintained Outperform and raised its target to $19.
What is the VSTM price target?
The average analyst price target for VSTM is $18.00, ranging from $12 to $24, based on 7 analysts. Latest: RBC Capital maintains on Nov 6, 2026.
What do analysts rate VSTM?
Analyst ratings for VSTM: 1 Buy, 19 Hold, 0 Sell — consensus Hold.
Did VSTM beat earnings?
VSTM last reported on Nov 5, 2026: EPS -$0.74 vs -$0.47 expected — a miss of 56.4%.
Does VSTM pay a dividend?
VSTM does not currently pay a dividend.
What are VSTM support and resistance levels?
Support: $7.72, $6.70, $5.54. Resistance: $8.60, $10.10, $10.82.
What are insiders doing with VSTM?
Insider activity: SELLING, 0 buys and 6 sells in the last 90 days.
What is the latest news on VSTM?
Nov 6, 2026: RBC Capital Markets changes its price target for Verastem · Nov 6, 2026: RBC Capital keeps Outperform rating on Verastem, cuts price target to $18 · Nov 6, 2026: HC Wainwright keeps Buy rating on Verastem, lifts target to $20